Jacobs Levy Equity Management, Inc Otonomy, Inc. Transaction History

Jacobs Levy Equity Management, Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.2 $137,230 - $247,464	-112,484 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.67 $231,717 - $300,332	112,484 New	112,484 $251,000
Q1 2021 May 17, 2021	SELL	$2.49 - $6.23 $238,761 - $597,382	-95,888 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.48 - $6.47 $40,945 - $76,126	-11,766 Reduced 10.93%	95,888 $620,000
Q3 2020 Nov 16, 2020	BUY	$3.16 - $4.36 $157,459 - $217,254	49,829 Added 86.17%	107,654 $436,000
Q2 2020 Aug 17, 2020	BUY	$1.87 - $3.84 $51,540 - $105,838	27,562 Added 91.07%	57,825 $209,000
Q1 2020 May 15, 2020	SELL	$1.58 - $4.06 $60,637 - $155,814	-38,378 Reduced 55.91%	30,263 $60,000
Q4 2019 Feb 14, 2020	SELL	$2.13 - $3.83 $29,607 - $53,237	-13,900 Reduced 16.84%	68,641 $263,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $2.86 $17,504 - $23,615	-8,257 Reduced 9.09%	82,541 $197,000
Q2 2019 Aug 13, 2019	SELL	$2.35 - $3.09 $36,615 - $48,145	-15,581 Reduced 14.65%	90,798 $250,000
Q1 2019 May 14, 2019	BUY	$1.8 - $2.97 $90,126 - $148,707	50,070 Added 88.92%	106,379 $280,000
Q4 2018 Feb 14, 2019	BUY	$1.51 - $2.93 $10,717 - $20,797	7,098 Added 14.42%	56,309 $104,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.95 $137,082 - $208,259	-52,724 Reduced 51.72%	49,211 $135,000
Q2 2018 Aug 14, 2018	SELL	$3.7 - $4.75 $1,110 - $1,425	-300 Reduced 0.29%	101,935 $392,000
Q1 2018 May 15, 2018	BUY	$4.05 - $6.1 $414,051 - $623,633	102,235 New	102,235 $429,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.